SciELO - Scientific Electronic Library Online

vol.113 issue4Oxygen saturation, periodic breathing and apnea during sleep in infants 1 to 4 month old living at 2,560 meters above sea levelInfant Mortality in Argentina: reducibility criteria, 3rd review author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand




  • Have no cited articlesCited by SciELO

Related links

  • Have no similar articlesSimilars in SciELO


Archivos argentinos de pediatría

Print version ISSN 0325-0075


MELLEN, César Hernán; IZBIZKY, Gustavo  and  OTANO, Lucas. Update on the use of magnesium sulphate for fetal neuroprotection in preterm birth. Arch. argent. pediatr. [online]. 2015, vol.113, n.4, pp.345-351. ISSN 0325-0075.

The administration of magnesium sulphate to mothers at risk for preterm birth for fetal neuroprotection has demonstrated to reduce the risk of cerebral palsy and gross motor dysfunction by 30-40%. Although there is controversy regarding the regimen of administration of magnesium sulphate, the gestational age limit, the extent of its potential benefit or even if it provides any benefit, current evidence is enough to support the use of magnesium sulphate in women at imminent risk for preterm delivery before 32 weeks of gestation. The objective of this study is to describe available evidence and current recommendations regarding neuroprotection with magnesium sulphate.

Keywords : Magnesium sulphate; Preterm birth; Cerebral palsy; Neuroprotective agents; Pregnancy.

        · abstract in Spanish     · text in Spanish     · English ( pdf ) | Spanish ( pdf )


Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License